anmelden
AstraZeneca Aktie
146,40
EUR
+0,25
EUR
+0,17
%
146,30
EUR
+0,60
EUR
+0,41
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 226,49 Mrd. EUR
KGV 27,55 Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Werbung
AstraZeneca Aktie Analyse
| 04.06.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.06.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.05.21 | AstraZeneca buy | Kepler Cheuvreux | |
| 20.05.21 | AstraZeneca buy | UBS AG | |
| 12.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 11.05.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 07.05.21 | AstraZeneca buy | UBS AG | |
|
Werbung
|
|||
| 04.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 04.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 03.05.21 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.05.21 | AstraZeneca Verkaufen | DZ BANK | |
| 03.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.21 | AstraZeneca buy | UBS AG | |
| 30.04.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 30.04.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 19.04.21 | AstraZeneca buy | UBS AG | |
| 14.04.21 | AstraZeneca buy | UBS AG | |
| 08.04.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.04.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.04.21 | AstraZeneca buy | UBS AG | |
| 26.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | AstraZeneca buy | UBS AG | |
| 22.03.21 | AstraZeneca overweight | Barclays Capital | |
| 22.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.03.21 | AstraZeneca buy | Deutsche Bank AG | |
| 17.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.03.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 08.03.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.21 | AstraZeneca kaufen | Barclays Capital | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 01.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 18.02.21 | AstraZeneca Neutral | UBS AG | |
| 17.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 11.02.21 | AstraZeneca Neutral | UBS AG | |
| 11.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.02.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 08.02.21 | AstraZeneca Neutral | UBS AG | |
| 03.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 01.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 26.01.21 | AstraZeneca Neutral | UBS AG | |
| 25.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
Werbung
Werbung
